Cellular Adhesion Molecules: Function, Types, and Roles

Cellular adhesion molecules are the proteins that physically connect cells to one another and to their surrounding environment, and without them your body would literally fall apart. These surface proteins do far more than act as passive glue: they relay signals that govern how cells move, divide, and organize into functioning tissues. There are several major families, each built differently and suited to different jobs, and their malfunction sits at the heart of conditions ranging from inflammatory bowel disease to metastatic cancer.

Cadherins and the Calcium Connection

Cadherins are a family of adhesion molecules that bind matching cadherins on neighboring cells in a calcium-dependent way. The name itself comes from “calcium-dependent adherent.” When calcium is present in the space between cells, the outer portions of cadherin molecules stiffen into a shape that promotes bonding. Remove the calcium and part of that bond loosens almost immediately, within about a second, though some cadherin interactions remain stable even without calcium, suggesting at least two distinct binding modes operate simultaneously.¹

Individual cadherin molecules are relatively weak on their own. Their strength comes from pairing up side by side on the same cell surface, a step called lateral dimerization. Experiments with purified cadherin segments showed that dimers retain substantially more binding ability than lone molecules, which means the cell can tune its stickiness by controlling how many cadherins cluster together at a given spot.² That tunability matters because cells constantly need to switch between holding tight and letting go, for instance when a wound is healing or an embryo is reshaping itself.

Different tissues express different cadherins. E-cadherin dominates in epithelial layers like skin and the gut lining. N-cadherin is prominent in nerve and muscle cells. This specificity helps sort cells during development: cells expressing the same cadherin type tend to cluster together, which is one reason your liver stays separate from your lungs.

Integrins and Two-Way Signaling

If cadherins are the bonds between neighboring cells, integrins are the anchors that tie cells to the scaffolding around them, a mesh of structural proteins called the extracellular matrix. Each integrin is built from two subunits, alpha and beta, paired together. The combination of subunits determines which matrix protein the integrin grabs onto, giving cells a versatile toolkit for attaching to different surfaces.

What makes integrins unusual is that they signal in both directions through the cell membrane. In “inside-out” signaling, the cell’s internal machinery pushes the integrin into a high-affinity shape so it can latch onto something outside. In “outside-in” signaling, the act of binding an external ligand triggers changes inside the cell that drive spreading, migration, or growth.³ This two-way communication happens through dramatic shape changes in the integrin structure, where signals cross multiple protein domains between the binding site and the cell interior.⁴

For most cells, movement follows a cycle: the front of the cell pushes forward, new integrin-based adhesions form to grip the surface, traction pulls the cell body along, and old adhesions at the rear release.⁵ This cycle repeats continuously in migrating cells, whether they are immune cells heading toward an infection or cancer cells invading new tissue.

How Immune Cells Find Infected Tissue

When you get an infection or injury, immune cells circulating in the bloodstream need to exit through the walls of nearby blood vessels and enter the affected tissue. This exit process follows a well-defined sequence of steps, each orchestrated by a different set of adhesion molecules.⁶

Selectins handle the opening act. These are adhesion molecules on both white blood cells and the blood vessel lining that grab onto sugar-decorated partners on the opposite surface. The binding is fast and brief, causing immune cells to slow down and tumble along the vessel wall in a motion researchers call “rolling.” E-selectin and P-selectin sit on activated endothelial cells lining the vessel, while L-selectin is found on leukocytes themselves.⁷

Selectin bonds have a counterintuitive property: moderate pulling force actually makes them last longer before they eventually slip. This “catch-slip” behavior explains why a certain minimum level of blood flow shear is needed for stable rolling. Too little flow and the bonds break too quickly; a bit more force and the bonds paradoxically strengthen, keeping the cell tethered.⁸

Once a rolling immune cell encounters chemical alarm signals from the inflamed tissue, its integrins snap into their high-affinity state. The cell then locks down firmly onto molecules like ICAM-1 and VCAM-1 on the vessel wall. From there, the cell squeezes between or through endothelial cells and enters the tissue, a process called transmigration. The adhesion molecule PECAM-1, a member of the immunoglobulin superfamily, helps guide this final step.⁷ Tumor cells exploit a strikingly similar sequence to spread through the body, though they rely on somewhat different molecular players.⁹

The Immunoglobulin Superfamily in the Nervous System

The immunoglobulin superfamily of cell adhesion molecules, or IgSF CAMs, is a large and diverse group whose members share a structural motif originally identified in antibody molecules. Unlike cadherins, many IgSF CAMs do not need calcium to function.¹⁰ ICAM-1 and VCAM-1, the molecules that immune cells grab onto during inflammation, belong to this family. But some of the most fascinating IgSF work happens in the developing brain.

NCAM, the neural cell adhesion molecule, helps growing nerve fibers find their correct targets. In experiments with mice lacking NCAM, nerve fibers heading from the thalamus to the cortex took wrong turns and, in some cases, never reached their destination at all. The resulting brain showed abnormal organization of the sensory maps that let the brain interpret touch.¹¹

Another set of IgSF members, the SynCAMs, were initially known for helping build synapses, the communication points between neurons. More recent work shows they also guide growing sensory nerve fibers into the correct entry zones of the spinal cord by mediating contact between neighboring axons, essentially keeping bundles of fibers organized as they navigate.¹² The nervous system, in other words, is wired partly through the same adhesion logic that holds the rest of the body together.

Tight Junctions and Barriers Between Cells

Not all adhesion is about sticking cells together mechanically. Tight junctions form a seal between cells in epithelial layers, controlling what can and cannot slip through the gaps. The key molecules here are claudins, a family of at least 24 members that create the seal and determine its selectivity, essentially forming tiny pores that let certain ions or small molecules pass while blocking others.¹³ Different tissues express different combinations of claudins, which is why the gut lining has very different permeability properties from the kidney tubule or the blood-brain barrier.¹⁴

Working alongside tight junctions, desmosomes provide mechanical bracing. These junctions connect the internal scaffolding of adjacent cells into a continuous network, distributing physical stress across a tissue so no single cell bears the full load. Skin, heart muscle, and the gut lining, all tissues that endure constant stretching and compression, rely heavily on desmosomes.¹⁵ Meanwhile, adherens junctions, built from cadherins, act as force sensors that detect and transmit mechanical signals, linking physical force to the cell’s internal signaling networks.¹⁶

Adhesion Molecules in Cancer and Metastasis

Cancer researchers noticed decades ago that tumor cells often lose their normal adhesion molecules, and that loss is a red flag for aggressive disease. E-cadherin, the epithelial cadherin, acts as a tumor suppressor. When its expression drops, cells loosen from their neighbors and gain the ability to migrate, a transition that closely mirrors a normal developmental process called epithelial-to-mesenchymal transition.¹⁷ Embryonic neural crest cells undergo a remarkably similar switch, downregulating E-cadherin and upregulating N-cadherin to become motile and migrate throughout the body during development.¹⁸ Cancer cells, in a sense, reactivate this ancient program at the wrong time and place.

Integrins play a separate role in tumor growth through their involvement in angiogenesis, the formation of new blood vessels that feed a growing tumor. One integrin in particular, αvβ3, is heavily expressed on the surface of activated endothelial cells and new blood vessels but is largely absent from resting vasculature. This difference makes it an attractive therapeutic target.¹⁹ Blocking αvβ3 with antibodies or peptide antagonists has been shown to disrupt new vessel growth without harming existing blood vessels, and in some animal tumor models this led to tumor regression and near-complete elimination of viable tumor cells.²⁰

Atherosclerosis and Inflamed Blood Vessels

The same adhesion molecules that recruit immune cells to fight infection can cause trouble when inflammation becomes chronic. In atherosclerosis, endothelial cells lining the arteries become activated, often in response to high cholesterol, and ramp up their display of VCAM-1 and ICAM-1. Studies in cholesterol-prone mice showed that VCAM-1 appeared on endothelial cells at sites predisposed to plaque formation before any visible lesion had developed, and its expression increased with cumulative cholesterol exposure. ICAM-1 was also prominent at these sites, though its levels seemed less tied to cholesterol and more to location-specific flow patterns.²¹

Once these molecules are displayed, white blood cells latch on and burrow into the artery wall, kicking off the cycle of inflammation that eventually builds a fatty plaque. Because VCAM-1 upregulation appears so early in the disease process, it has attracted interest as both a biomarker and a drug target for preventing plaque development.²²

How Pathogens Exploit Adhesion

Bacteria, viruses, fungi, and parasites have evolved to hijack host adhesion molecules as entry points or footholds. Many bacterial pathogens latch onto cell adhesion molecules as an initial step in infection, sometimes by mimicking the molecules’ normal binding partners.²³ Once bound, the pathogen can trigger the signaling pathways the adhesion molecule normally activates, using the host cell’s own machinery to gain entry or establish a persistent foothold.

The list of bacteria known to exploit adhesion molecules is long and includes some of the most significant human pathogens: the organisms behind tuberculosis, listeriosis, dysentery, gonorrhea, whooping cough, and Lyme disease, among others.²⁴ This creates a paradox for the immune system: the very molecules that recruit defensive cells to a site of infection are sometimes the same molecules the pathogen is using to establish itself there.

Drugs That Target Adhesion Molecules

Because adhesion molecules sit at the crossroads of inflammation, the idea of blocking them therapeutically has been tested most thoroughly in inflammatory bowel disease. The gut-specific integrin α4β7 directs immune cells toward the intestinal lining, and blocking it can reduce the inflammatory onslaught that damages the gut in Crohn’s disease and ulcerative colitis.

Natalizumab, an antibody against the α4 integrin subunit, was the first anti-integrin therapy approved for moderately to severely active Crohn’s disease, but its use is restricted because blocking α4 broadly can interfere with immune surveillance in the brain, raising the risk of a rare and serious brain infection called progressive multifocal leukoencephalopathy.²⁵ Vedolizumab, which targets the paired α4β7 integrin rather than the α4 subunit alone, narrows the blockade to gut-homing immune cells and has a more favorable safety profile. It is now the most widely used anti-integrin therapy in inflammatory bowel disease, approved for both ulcerative colitis and Crohn’s disease.²⁵ Natalizumab remains an option for patients who have not responded to other treatments, including anti-TNF drugs.²⁶

The lesson from these drugs is that specificity matters enormously. Blocking an adhesion molecule broadly can cripple immune defenses in unexpected places, while targeting a more selective molecule or a tissue-specific form can achieve the therapeutic benefit with fewer side effects.

Tissue Engineering with Adhesion Peptides

Researchers building artificial scaffolds for tissue repair face a fundamental problem: cells placed on a bare synthetic surface have no molecular handholds and struggle to attach, spread, and grow. The solution, increasingly, is to coat scaffolds with short peptide sequences that mimic the binding sites on natural matrix proteins. The most widely used of these is RGD, a three-amino-acid motif (arginine-glycine-aspartic acid) recognized by many integrins.²⁷

The results can be dramatic. In one study, bone marrow stromal cells grown in hydrogels containing RGD peptides showed a more than thirteen-fold increase in the production of an enzyme marker for bone formation compared to cells in gels without RGD, with the effect increasing at higher peptide concentrations.²⁸ Cyclic RGD peptides, which are more stable and selective than linear ones, have also been used to coat scaffolds for cartilage repair, with chondrocytes successfully attaching and functioning on coated surfaces.²⁹ Essentially, by borrowing the language of adhesion molecules, engineers can trick cells into treating a synthetic scaffold like home.

The Constant Recycling of Adhesion Molecules

A common misconception is that adhesion molecules are static fixtures, glued into the cell membrane and staying put. In reality, cells continuously pull adhesion molecules off their surface, sort them internally, and either send them back to the membrane or destroy them. This recycling is what allows a migrating cell to maintain a moving front and a releasing rear at the same time.

The neural adhesion molecule L1 demonstrates this vividly in growing nerve fibers. L1 is pulled inside the cell at the rear of the growth cone, ferried forward in internal compartments, and then reinserted at the leading edge, creating a kind of molecular treadmill that helps the nerve fiber advance.³⁰ Integrins follow a similar logic during cell migration: after being internalized, they pass through recycling compartments and are delivered back to the cell surface through a pathway that routes them through a sorting station near the cell’s packaging center before returning them to the leading edge.³¹

Cadherins, too, are continually endocytosed and either recycled or sent for degradation, and the balance between those two fates determines how strongly cells stick together at any given moment.³² During embryonic development, shifting this balance allows tissues to reshape themselves rapidly, while in cancer, excessive degradation of cadherins can loosen cells and promote metastasis.

Measuring the Strength of a Single Bond

Much of what we know about adhesion molecules at the finest scale comes from atomic force microscopy, a technique that can measure forces in the piconewton range, roughly a trillionth of the force you feel holding a paperclip. Researchers attach a single cell or purified adhesion molecule to the microscope’s tiny sensor, bring it into contact with a partner molecule, and then slowly pull them apart while recording the force required. This approach has been used to measure the adhesion force of a single bond between individual adhesion molecules on the surface of amoeba-like cells.³³

Applied to cadherins, single-molecule force spectroscopy has revealed that E-cadherin and N-cadherin, despite their structural similarity, form bonds with markedly different mechanical properties. N-cadherin bonds and E-cadherin bonds differ in adhesion force and in how they respond to pulling, and their energy landscapes look qualitatively different, meaning they break apart through distinct mechanisms.³⁴ Findings like these help explain why swapping one cadherin for another during development, as neural crest cells do, has such a profound effect on cell behavior: the replacement is not a simple substitution but a genuine change in the physics of how cells hold onto each other.